Refresh LACRI-LUBE Eye Ointment Recalled for Potential Tube Seal Breach
Allergen is recalling specific lots of Refresh LACRI-LUBE eye ointment (763,426 tubes) due to potential breaches in the tube seal that may compromise sterility. Consumers should verify their product lot number against the recall list.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a Class II FDA recall for a potential sterility breach in an ophthalmic product with no reported illnesses or injuries. Per the severity rubric, this qualifies as a risk-of-harm product where injury has not yet been reported, warranting a High (3) classification.
Plain-English summary
Allergen, an AbbVie company, is recalling specific lots of Refresh LACRI-LUBE lubricant eye ointment in 0.12 oz (3.5g) tubes due to a potential lack of assurance of sterility. The impacted lots may contain a breach in the tube seal.
The recall affects approximately 763,426 tubes distributed nationwide in the USA and in Australia, Canada, and Great Britain. Affected lot numbers and expiration dates are publicly available from the manufacturer.
Consumers who possess Refresh LACRI-LUBE should verify their product's lot number and expiration date against the manufacturer's recall list. If their product is among the recalled lots, the product should not be used.
The recalled product
- Product
- Refresh LACRI-LUBE, (42.5% Mineral Oil, 57.3% White Petrolatum) Lubricant Eye Ointment, Net wt, 0.12 oz (3.5g) Tube, Distributed by: Allergen, an AbbVie company, Madison, NJ 07940, UPC code: 300230312042
- Manufacturer
- AbbVie Inc.
- Category
- Drug — Ophthalmic / Eye Care
- Hazard
- sterility-breach
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot: 387489
- Exp. Oct 24
- 387490
- Exp. Jun 25
- 390422
- Exp. Nov 24
- 390424
- 391692
- 391893
- Exp. Nov 25
- 394822
- Exp. Feb 26
- 395991
- Exp. Mar 26
- 397905
- 397973
- 397974
- Exp May 26
- 399019
- 399254
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27